FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Total Non-Current Liabilities | ₹67 Cr | ₹18 Cr |
What is the latest Total Non-Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹67 Cr |
| Mar2025 | ₹18 Cr |
How is Total Non-Current Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹67 Cr | 274.31 | |
| Mar2025 | ₹18 Cr | - | |
Compare Total Non-Current Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹2,553.8 Cr | 9.3% | 6.1% | 179.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 9.3% |
6.1% |
179.8% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses